Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV002282514 | SCV002571343 | pathogenic | not provided | 2022-03-10 | criteria provided, single submitter | clinical testing | Promoter variant in a gene for which loss-of-function is a known mechanism of disease; transcript analysis supports that this variant abolishes transcription by disrupting the binding site for the Sp1 transcription factor consistent with a null allele (Gardella et al., 2000); No data available from control populations to assess the frequency of this variant; This variant is associated with the following publications: (PMID: 10980546) |
Biomedical Innovation Departament, |
RCV001310293 | SCV001500028 | pathogenic | Epidermolysis bullosa dystrophica | 2018-11-22 | no assertion criteria provided | research |